Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 4Adenoma 4Polyps 3Neoplasms 3Colonic Polyps 3Adenomatous Polyps 2Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Irritable Bowel Syndrome 1Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Endoscopy 3Colonoscopy 3Eicosapentaenoic Acid 2Uterine Myomectomy 1Sennosides 1Restraint, Physical 1Polyethylene Glycols 1Metoclopramide 1Erythromycin 1Docosahexaenoic Acids 1Diatrizoate Meglumine 1Colonography, Computed Tomographic 1Clinical Chemistry Tests 1Bisacodyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Polyps × Colonoscopy × Clear all
NCT02893748 2019-09-23

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

HyGIeaCare, Inc.

Phase NA Withdrawn

Neoplasms, Polyps

NCT02926209 2019-07-16

Post Market Evaluation of Aer-O-Scope Visualization

GI View Ltd.

Phase NA Terminated
104 enrolled 5 charts

Adenoma, Neoplasms, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡